Breast Cancer Trials: The PREDICT Registry:
A Prospective Study to Evaluate the Effect of the DCISionRT Test on Treatment Decisions in Patients with DCIS Following Breast-Conserving Therapy
Quality of Life Studies Trials: Cancer Genetic Syndromes Study:
A prospective survey of the patients’ understanding on genetic tests for cancer genetic syndromes
Quality of Life Studies Trials: NATERA:
The usage of cell free DNA test for monitoring tumor response or minimal residual disease in pan-tumor types.
Pediatric Oncology: Lymphoblastic Leukemia Trials: AALL1732
A Phase 3 Randomized Trial of Inotuzumab Ozogamicin (IND#:133494, NSC#: 772518) for Newly Diagnosed High-Risk B-ALL; Risk-Adapted Post-Induction Therapy for High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and Disseminated B-LLy
Pediatric Oncology: Neuroblastoma Trials: ANBL1531
A Phase 3 Study of 131I-Metaiodobenzylguanidine (131I-MIBG) or ALK Inhibitor Therapy Added to Intensive Therapy for Children with Newly Diagnosed High-Risk Neuroblastoma (NBL)
Pediatric Oncology: Myeloid Leukemia Trials: AAML1831
Phase 3 Randomized Trial for Patients with de novo AML Comparing Standard Therapy Including Gemtuzumab Ozogamicin (GO) to CPX-351 with GO, and the Addition of the FLT3 Inhibitor Gilteritinib for Patients with FLT3 Mutations
Pediatric Oncology: Lymphoblastic Leukemia Trials: AALL1821
A Phase 2 Study of Blinatumomab (NSC# 765986, IND# 125462) in Combination with Nivolumab (NSC # 748726, IND# 125462), a Checkpoint Inhibitor of PD-1, in B-ALL Patients Aged ≥ 1 to < 31 Years Old with First Relapse
Pediatric Oncology: Lymphoblastic Leukemia Trials: AALL 1621
A Phase 2 Study of Inotuzumab Ozogamicin (NSC# 772518, IND#133494) in Children and Young Adults with Relapsed or Refractory CD22+ B-Acute Lymphoblastic Leukemia (B- ALL)
Pediatric Oncology: Childhood Germ Cell Tumor Trials: AGCT 1531
A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients with Germ Cell Tumors
Pediatric Oncology: Brain Tumor Trials: ACNS 2021
A Phase 2 Trial of Chemotherapy followed by Response-Based Whole Ventricular & Spinal Canal Irradiation (WVSCI) for Patients with Localized Non-Germinomatous Central Nervous System Germ Cell Tumor.